Neuroblastoma - Epidemiology Insights to 2025

Publisher Name :
Date: 28-Jul-2017
No. of pages: 40
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Neuroblastoma -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Neuroblastoma in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Neuroblastoma. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Neuroblastoma. The report contains the targeted patient populations and the forecast methodology.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Key Coverage and Benefits

  • The Report includes the prevalent population and how will it change over the next eight years.

  • Coverage of key Neuroblastoma sub-populations and its prevalent or incident cases

  • Prevalent or incident cases segmented by age and sex.

  • The key differences in epidemiology patterns across the seven market segments.

Reasons to buy

  • Developing business strategies by understanding the trends shaping and driving the global Neuroblastoma market.

  • Identifying prevalent patient populations as well as risk factors in the global Neuroblastoma market will help to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Neuroblastoma therapeutics in each of the markets covered.

Neuroblastoma - Epidemiology Insights to 2025

Table of Contents

1. Report Introduction

2. Snapshot of Total Prevalent or Incident cases by 7 MM

3. Executive Summary
Key Findings

4. Neuroblastoma Overview
Neuroblastoma Definition
Pathophysiology
Symptoms
Etiology

5. Risk Factors Associated with Neuroblastoma

6. Disease Burden & Unmet Need in the Market

7. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2015-2025
Prevalent & Incident Cases by Category-2015-2025
Age-Specific Prevalent/ Incident Cases of Neuroblastoma
Sex-Specific Prevalent/Incident Cases of Neuroblastoma
Disease Type Specific Prevalent/Incident Cases of Neuroblastoma

8.Prevalent & Incident Cases by 7 MM-2015-2025
Neuroblastoma Epidemiology of United States-2025
Neuroblastoma Epidemiology of United Kingdom-2025
Neuroblastoma Epidemiology of Germany-2025
Neuroblastoma Epidemiology of France-2025
Neuroblastoma Epidemiology of Spain-2025
Neuroblastoma Epidemiology of Italy-2025
Neuroblastoma Epidemiology of Japan-2025

9. Key Takeaways

10. Appendix

11.Report Methodology

12. Consulting Services

13. Disclaimer

14. About Us

List of Tables

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Neuroblastoma Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Neuroblastoma (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Neuroblastoma By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Neuroblastoma Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Neuroblastoma (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Neuroblastoma By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Neuroblastoma Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Neuroblastoma (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Neuroblastoma By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Neuroblastoma Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Neuroblastoma (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Neuroblastoma By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Neuroblastoma Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Neuroblastoma (Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Neuroblastoma By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Neuroblastoma Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Neuroblastoma (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Neuroblastoma By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Neuroblastoma Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Neuroblastoma (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Neuroblastoma By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Neuroblastoma Sub-population, Japan (2015-2025)

List of Figures

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Neuroblastoma Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Neuroblastoma (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Neuroblastoma By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Neuroblastoma Sub-population,US (2015-2025)
Figure 7: Prevalent Cases of Neuroblastoma (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Neuroblastoma By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Neuroblastoma Sub-population,United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Neuroblastoma (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Neuroblastoma By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Neuroblastoma Sub-population,Germany (2015-2025)
Figure 13: Prevalent Cases of Neuroblastoma (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Neuroblastoma By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Neuroblastoma Sub-population,France (2015-2025)
Figure 16: Prevalent Cases of Neuroblastoma (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Neuroblastoma By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Neuroblastoma Sub-population,Italy (2015-2025)
Figure 19: Prevalent Cases of Neuroblastoma (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Neuroblastoma By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Neuroblastoma Sub-population,Spain (2015-2025)
Figure 22: Prevalent Cases of Neuroblastoma (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Neuroblastoma By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Neuroblastoma Sub-population,Japan (2015-2025)
  • Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 254
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2017, provides an overview of the Human Papillomavirus (HPV) Associated Cancer (Oncology) pipeline landscape.Human papillomavirus (HPV) is the most common viral infection of the reproductive tract. Human papillomavirus (HPV) has been found to be associated with several types of cancer. Risk factors include smoking, weakened immune system, long-......
  • Peritoneal Cancer - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 876
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peritoneal Cancer - Pipeline Review, H2 2017, provides an overview of the Peritoneal Cancer (Oncology) pipeline landscape.Peritoneal cancer is a rare cancer that develops in the peritoneum, a thin, delicate sheet that lines the inside wall of the abdomen and covers the uterus and extends over the bladder and rectum. Peritoneal cancer usually manifests with abdominal distention and diffuse nonspecific abdominal......
  • Rhabdomyosarcoma - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 226
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rhabdomyosarcoma - Pipeline Review, H2 2017, provides an overview of the Rhabdomyosarcoma (Oncology) pipeline landscape.Rhabdomyosarcoma (RMS) is a malignant tumor of connective tissue in which abnormal cells are thought to arise from primitive muscle cells. Symptoms include pain, fever, purplish discoloration of the eye, hearing loss, headaches, bulging of the eye, or a droopy eyelid and tingling or weakness.......
  • Fallopian Tube Cancer - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 875
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fallopian Tube Cancer - Pipeline Review, H2 2017, provides an overview of the Fallopian Tube Cancer (Oncology) pipeline landscape.Fallopian tube cancer is also called tubal cancer. It develops in the fallopian tubes, which serve as a connection between the ovaries and the uterus. It occurs very rarely. The common symptoms of fallopian tube cancer may include abnormal vaginal bleeding, especially after menopaus......
  • Global Kaposi Sarcoma Market Size, Status and Forecast 2022
    Published: 06-Oct-2017        Price: US 3300 Onwards        Pages: 98
    This report studies the global Kaposi Sarcoma market, analyzes and researches the Kaposi Sarcoma development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Merck - Pfizer - Johnson & Johnson - GlaxoSmithKline - Bristol-Myers Squibb - Eli Lilly Market segment by Regions/Countries, this report covers - United States - EU - ......
  • Global Mucositis Partnering 2010-2017
    Published: 01-Oct-2017        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Mucositis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understan......
  • Global Breast Cancer Partnering 2010 to 2017
    Published: 01-Oct-2017        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Breast Cancer Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides under......
  • Global Bladder Cancer Partnering 2010 to 2017
    Published: 01-Oct-2017        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Bladder Cancer Partnering since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access ......
  • Global Brain Cancer Partnering 2010 to 2017
    Published: 01-Oct-2017        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Brain Cancer Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides unders......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs